From a Regulatory Medical Writer’s Perspective By ‘Femi Fajimi Clinical trial quality is often discussed in terms of compliance: whether the protocol follows Good Clinical Practice (GCP), whether the required procedures are documented, and whether the study records meet regulatory expectations. These remain essential considerations. However, compliance alone does not necessarily establish that a clinical…

Read more →